INTERVIEW: TMS-for-depression pioneer Neuronetics readies for commercial ramp-up
This article was originally published in Clinica
Being first to market is not always what it’s cracked up to be, especially when your product is an innovative technology. Not only do you have to get the first adopters on board, there is also the issue of securing reimbursement to spur uptake of your product. The latter is particularly challenging when there is no existing code for your innovation and you need to create your own reimbursable market.